Pneumococcal Conjugate Vaccine enters Universal Immunization Program in five Indian States

2016-11-09 08:17:51

The Health Ministry approved the introduction of Pneumococcal Conjugate Vaccine (PCV) under Universal Immunization Program in Himachal Pradesh, Bihar, Uttar Pradesh, Rajasthan and Madhya PradeshBy Team ABLEFive states see introduction of Pneumococcal Conjugate Vaccine (PCV) in their universal immunization programs. “we have achieved a new milestone towards expanding the coverage of full immuniza

Read more

AYUSH Minister inaugurates 9th International Regulatory Cooperation Meeting for Herbal Medicines

2016-11-09 08:12:22

The three-day meet has been organised by the Ministry of AYUSH in New Delhi from November 8-10, 2016. Over 33 delegates from 17 countries are participating in the three day-long Annual Meeting of IRCH.By Team ABLEThe Minister of State for AYUSH (Independent Charge), Mr Shripad Yesso Naik inaugurated the 9th Annual Meeting of International Regulatory Cooperation for Herbal Medicines (IRCH) in New D

Read more

Novozymes launches world’s first biological foam control for sugarcane ethanol

2016-11-09 08:10:54

Novozymes’ Fermax is an enzyme protease that replaces chemicals in the sugarcane ethanol production process. By Team ABLENovozymes, the leading technology provider for biofuel industries, has launched Fermax, an enzyme protease that prevents foam development during the sugarcane ethanol fermentation process, while delivering improved control and replacing chemicals. For an average size plant, tr

Read more

GreenSignal Bio Pharma seeks to raise funds through IPO

2016-11-09 08:09:42

GreenSignal Bio Pharma is coming up with an IPO from November 9–11, 2016 to raise around Rs 116 crore through an offer for sale.By Team ABLEChennai-based BCG vaccine manufacturer GreenSignal Bio Pharma is coming up with an IPO from November 9–11, 2016 to raise around Rs 116 crore through an offer for sale (OFS). The firm’s existing shareholders will sell 14,579,560 equity shares for face val

Read more

US-based Walter Reed starts testing Zika vaccine in humans

2016-11-09 08:06:52

Walter Reed Army Institute of Research began the first of five early stage clinical trials to test the safety and ability of an investigational Zika purified inactivated vaccine.By Team ABLEAs India’s very own Bharat Biotech is awaiting approval from the Drug Controller General of India for its Zikavac to be tested on humans, American military research agency, Walter Reed Army Institute of Resea

Read more

India-UK Tech Summit translates deeper ties on vaccine, anti-microbial resistance research initiatives

2016-11-07 08:57:16

At the India-UK Joint Tech Summit, Prime Minister Narendra Modi announced that the two countries will focus on new vaccines for infectious diseases and launch a new Anti-Microbial Resistance initiative with joint investment of 15 million pounds. By Team ABLEAt the ongoing India-UK Tech Summit jointly inaugurated by the Prime Minister of India Narendra Modi and the Prime Minister of United Kingdom,

Read more

ICMR calls for vaccine manufacturers to report status/details on vaccine candidates for arboviral diseases

2016-11-07 08:55:03

ICMR has announced that it would like to review the available vaccines as well as vaccine candidates for arboviral diseases prevalent or posing a threat to the Indian subcontinent .By Team ABLEIndian Council of Medical Research’s Division of Epidemiology & Communicable Diseases has called for a write up on Vaccine/Vaccine Candidates for Arboviruses. The Companies Secretary, Department of Hea

Read more

European Medicines Agency accepts to review Biocon-Mylan co-developed insulin glargine

2016-11-04 10:33:42

The European Medicines Agency (EMA) has accepted for review Mylan’s Marketing Authorization Application (MAA) for insulin glargine, which is co-developed by Biocon. By Team ABLEIndia’s leading biotechnology company Biocon and NASDAQ-listed Mylan have jointly announced that the European Medicines Agency (EMA) has accepted for review Mylan’s Marketing Authorization Application (MAA) for insuli

Read more

Safety concerns linger for generic oncology drugs in developing countries

2016-11-04 10:30:36

After analyzing safety data, International researchers have found that generic cancer drugs are generally safe in countries with rigorous regulatory programs similar to the FDA in the United States. However, in countries with less rigorous regulation, such as India, Iraq and Colombia, safety is far from certain.By Team ABLEAn international research team led by Dr Charles Bennett, Josie M Fletcher,

Read more

Advanced Enzymes acquires 70% stake in API maker JC Biotech

2016-11-04 10:14:12

This deal by Advanced Enzymes is to strengthen its leadership in API Serratiopeptidase with over 80%  market share and make a foray into biopharma and Algal DHA.By Team ABLEAdvanced Enzyme Technologies,  a  leading  specialty  biotech  company in enzymes, has entered into definitive agreements with API maker JC Biotech to acquire a 70% stake for a consideration of Rs

Read more